Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

NCT03604978 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

NIH

Sponsor class

Conditions

Grade 2 Meningioma
Grade 3 Meningioma
Recurrent Meningioma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Echocardiography Test
BIOLOGICAL: Ipilimumab
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
RADIATION: Stereotactic Radiosurgery

Sponsor

National Cancer Institute (NCI)